How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin

Size: px
Start display at page:

Download "How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin"

Transcription

1 How does polydrug use contribute to heroin overdose deaths? Risk to heroin users of concurrent use of pregabalin and gabapentin Graeme Henderson Suzanne Audrey Matt Hickman Abi Lyndon Rob Hill Claudia Wells Erica Burnell Suzanne Ingle University of Bristol Bristol, UK & Office of National Statistics

2 How does polydrug use contribute to heroin overdose deaths? Why are heroin users in Bristol also taking pregabalin and gabapentin?

3 Pharmacology of gabapentinoids Gabapentin Pregabalin Oral absorption <50% >90% (saturable) (non saturable) Time to maximum 2-3 hours 1 hour plasma concentration Excretion renal renal (not metabolised) (not metabolised) Half life in body ~6 hours ~6 hours

4 Pregabalin and gabapentin community prescriptions (England) Gabapentoid prescriptions (m illions) Year Epilepsy Pain Anxiety (pregabalin) insomnia, migraine, mania, and bipolar disorder as well as alcohol withdrawal (gabapentin)

5 Pregabalin and gabapentin community prescriptions (England) Gabapentoid prescriptions (m illions) Year Abuse relaxation enhanced sociability euphoria insomnia, migraine, mania, dissociation and bipolar disorder as sedation well as alcohol withdrawal (gabapentin) Epilepsy Pain Anxiety (pregabalin)

6 Acute deaths involving gabapentin and pregabalin (England & Wales) Deaths mentioning a gabapentoid Year

7 Correlation between number of prescriptions and number of deaths in a year B 5 Log number of deaths Gabapentoid prescriptions (per 100,000) 5% increase in overdose deaths per increase in prescriptions

8 Comparison of acute deaths involving gabapentin and pregabalin in Scotland with those in England & Wales 2016 Scotland England & Wales Gabapentin Pregabalin Total

9 Deaths also involving opioids (England & Wales) Deaths mentioning a gabapentoid Opioids were involved in >80% of gabapentoid deaths (90% in 2016) Year

10 Deaths also involving opioids (England & Wales) Deaths mentioning a gabapentoid Year Is the presence of both just because heroin addicts like gabapenintoids or is there an interaction?

11 Qualitative Research (October 2014 February 2015) Interviews with active heroin users in Bristol - attending Bristol Drugs Project Needle Exchange - screened for known opioid users - 10 fee on completion of interview Areas discussed Perceived protection - from on top heroin use on methadone or Subutex OST Benefits and hazards of also using non-opioid drugs - alcohol - cocaine - benzodiazepines - gabapentin and pregabalin

12 Interviewed 30 users - 19 males and 11 females - different lengths of opioid use 20 long term (>10 years) 4 medium term (5 10 years) 6 short term (<5 years) - different styles of use (smoking and injecting) - different opioid substitution treatments

13 Use of gabapentinoids - 21 of 30 had used gabapentinoids - most (19 of 21) used pregabalin - 3 were daily users - 3 used it weekly - 5 used it intermittently - for 10 it was just a one-off occasion Street purchase mainly - 2 obtained it from friends who were prescribed it - 3 were prescribed pregabalin for chronic pain Taken orally some time prior to heroin injection (unlike cocaine which is mixed with heroin and injected) Doses varied 250mg tablet to 1500mg taken orally as tablets

14 Perceived effects of gabapentinoids - give a buzz on their own (feeling of being drunk) - gouching -enhance the effect of the heroin - caused blackouts and loss of control (zombies) - increased the risk of overdose - helps to cope with withdrawal between heroin doses - reduced craving for heroin

15 Gabapentin Study Glasgow and Lanarkshire by Naloxone Peer Educators 41 individuals completed a brief questionnaire 50% had taken illicit gabapentin Swallowing > snorting >> injecting Taken along with other drugs - heroin 46%, methadone 39%, valium 44% Effects - sleepy, gouchy, chilled, laid back, relaxed Duration - effects lasted for 8 to 24 hours Risks - 50% believed it increased risk of overdose with other drugs

16 Preclinical studies of pregabalin - Does pregabalin depress respiration? - If so is it additive with opioids? - Does pregabalin alter opioid tolerance?

17 Monitoring mouse respiration

18 Pregabalin and morphine additively depress respiration Morphine 10 mg/kg Pregabalin 200 mg/kg 100 Pregabalin Minute volume(% predrug level) Time (min) Minute volume(% predrug level) Morphine/Saline Time (min)

19 Pregabalin opioid interaction Acute - pregabalin (high dose) additive with all opioids tested morphine methadone fentanyl oxycodone

20 Low dose pregabalin reverses morphine tolerance Pregabalin 20 mg/kg Morphine 10 mg/kg 6 day morphine treatment respiration A pregabalin 20 mg/kg drugs 100 naive 100 Minute volume (% predrug level) morphine pretreated Minute volume (% predrug level) morphine pretreated + morphine challenge morphine pretreated + pregabalin + morphine challenge Time post drug (min) Time post drug (min)

21 Pregabalin opioid tolerance Tolerance - pregabalin reversal of tolerance increases danger of heroin overdose - pregabalin (low dose) reverses morphine (heroin) tolerance oxycodone tolerance - pregabalin s long half life (6 h) will allow reversal of morphine tolerance hours after pregabalin is taken - no reversal of methadone tolerance

22 Drug specific mechanisms of opioid tolerance Methadone Morphine GRK2/3 p p arrestin PKCα,γ Methadone Fentanyl Morphine Heroin 6-MAM Oxycodone

23 Agonist specific mechanisms of opioid tolerance Methadone Morphine GRK2/3 p p arrestin PKCα,γ Alcohol Tamoxifen Pregabalin Methadone Fentanyl Morphine Heroin 6-MAM Oxycodone

24 Diversion of gabapentoid prescription - Need for greater awareness amongst GPs - Need for alternative treatments for chronic pain

25 HM Prison Service (South West of England) Dr Catherine Glover, Medical Director

Gabapentin Questionnaire

Gabapentin Questionnaire Gabapentin Questionnaire People Who Use Drugs Views! Jason Wallace National Naloxone Training and Support Officer Danny Hutcheson Glasgow Naloxone Peer Educator Lorraine Simpson Lanarkshire Naloxone Peer

More information

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,

More information

Risk to heroin users of polydrug use of pregabalin or gabapentin

Risk to heroin users of polydrug use of pregabalin or gabapentin RESEARCH REPORT doi:10.1111/add.13843 Risk to heroin users of polydrug use of pregabalin or gabapentin Abigail Lyndon 1, Suzanne Audrey 2, Claudia Wells 3, Erica S. Burnell 1, Suzanne Ingle 2,RobHill 1,

More information

Buprenorphine pharmacology

Buprenorphine pharmacology Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely

More information

The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users

The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users Jennifer R. Havens, PhD, MPH Center on Drug and Alcohol Research Goals Describe the epidemiology of gabapentin

More information

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith

Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

A prisoners guide to buprenorphine

A prisoners guide to buprenorphine A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw

More information

solutions MEDICATION MIS MANAGEMENT and Chronic Pain 10/4/2016 Opioid Abuse: Current Data Opioid Abuse: Current Data

solutions MEDICATION MIS MANAGEMENT and Chronic Pain 10/4/2016 Opioid Abuse: Current Data Opioid Abuse: Current Data MEDICATION MIS MANAGEMENT and Chronic Pain solutions Opioid Abuse: Current Data Americans consume 80% of the global supply of opioids This includes 99% of the world s hydrocodone and 2/3s of the world

More information

DRUG RELATED DEATHS AND PREGABALIN. Dr Abhishek Goli INSPIRE CGL

DRUG RELATED DEATHS AND PREGABALIN. Dr Abhishek Goli INSPIRE CGL DRUG RELATED DEATHS AND PREGABALIN Dr Abhishek Goli INSPIRE CGL INTRODUCTION 1. Overview on drug related deaths 2. Pregabalin and Gabapentin abuse potential 3. Benzos POTENTIAL FACTORS Increase in availability

More information

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Opioids and Overdose 2017

Opioids and Overdose 2017 Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

Take Home Naloxone: What Pharmacists Need to Know

Take Home Naloxone: What Pharmacists Need to Know Take Home Naloxone: What Pharmacists Need to Know Sheri L. Fandrey, BSP, PhD Knowledge Exchange Lead Manitoba Addictions Knowledge Exchange Conflict of Interest/Disclosure Dr. Sheri Fandrey Has no conflicts

More information

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

2004-L SEPTEMBER

2004-L SEPTEMBER BULLETIN INTELLIGENCE Buprenorphine: Potential for Abuse Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III

More information

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND

FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND FATAL POISONINGS BY MEDICINAL OPIOIDS IN FINLAND ERKKI VUORI 12.-13.11.2012 HJELT INSTITUUTTI OIKEUSLÄÄKETIETEEN OSASTO FINLAND IS AN IDEAL COUNTRY FOR POST- MORTEM TOXICOLOGICAL INVESTIGATIONS High autopsy

More information

Managing long term opioids and hypnotics. Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh

Managing long term opioids and hypnotics. Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh Managing long term opioids and hypnotics Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh Managing long term opioids and hypnotics Illicit opioid use Hypnotics - efficacy

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

Treatment of drug dependence What you need to know

Treatment of drug dependence What you need to know Treatment of drug dependence What you need to know Opioid Replacement Therapy for heroin and opioid dependence Information for family members and significant others Contents What help is there for family

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

Slow Release Opioids. Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For the Treatment of Pain

Slow Release Opioids. Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For the Treatment of Pain NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Slow Release Opioids Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For

More information

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response

Reducing Opioid Deaths: Arizona s Emergency Declaration & Response Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and

More information

New London CARES Coordinated Access, Resources, Engagement and Support

New London CARES Coordinated Access, Resources, Engagement and Support New London CARES Coordinated Access, Resources, Engagement and Support What are Opioids? Class of drugs that include Heroin Prescription pain relievers oxycodone (OxyContin), hydrocodone (Vicodin), codeine,

More information

Take Home Naloxone elearning Module Script

Take Home Naloxone elearning Module Script elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Opioid Addiction Statistics

Opioid Addiction Statistics May 2017 Opioid Addiction Statistics Definitions Heroin Epidemic - As pill mills close, prescribing is becoming tighter, demand among younger users rise, and dealer s profits rise, addicts are turning

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

Xanax help with opiate withdrawal

Xanax help with opiate withdrawal Xanax help with opiate withdrawal The Borg System is 100 % Xanax help with opiate withdrawal Mar 11, 2015. Subutex contains just buprenorphine without naloxone, and so while you won't go into withdrawal

More information

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been

More information

How long to wait between taking oxycodone and gabapentin

How long to wait between taking oxycodone and gabapentin How long to wait between taking oxycodone and gabapentin Search GO How long to wait between taking oxycodone and gabapentin Learn about drug interactions between gabapentin oral and hydrocodone- acetaminophen.

More information

Prescription Opioids

Prescription Opioids What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made

More information

Guide to the management of gabapentinoid misuse

Guide to the management of gabapentinoid misuse THERAPY FOCUS Guide to the management of GRAHAM PARSONS In light of the government s proposals to reclassify pregabalin and gabapentin as Class C controlled drugs due to the risk of misuse, this article

More information

Washington State s Overdose Epidemic

Washington State s Overdose Epidemic Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?

More information

RP PERCOCET STREET VALUE

RP PERCOCET STREET VALUE RP 5 325 PERCOCET STREET VALUE Rp 5 325 Percocet Street Value Max dose of percocet a day Urgent care percocet bothell wa 98012 directions I need a substitute for percocet 10/325 percocet Percocet constipation

More information

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic

More information

Opioid epidemic and PEHP

Opioid epidemic and PEHP Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe

More information

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)

More information

Drug Trend Bulletin - Issue 19 March 2019.

Drug Trend Bulletin - Issue 19 March 2019. - Issue 19 March 2019. THIS IS A REDACTED COPY OF AN INTERNAL POLICE DOCUMENT THAT PROVIDES INFORMATION AND ADVICE ON SOME OF THE LATEST DRUG TRENDS AROUND SCOTLAND. IF YOU HAVE ANY INFORMATION ABOUT EMERGING

More information

Opioid dependence and buprenorphine treatment

Opioid dependence and buprenorphine treatment Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions

More information

Prescription Opioid Addiction

Prescription Opioid Addiction CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett

More information

Substances under Surveillance

Substances under Surveillance Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of

More information

The Emergence of Gabapentin Misuse in the United States

The Emergence of Gabapentin Misuse in the United States The Emergence of Gabapentin Misuse in the United States Jennifer R. Havens, PhD, MPH Center on Drug and Alcohol Perspective and Rachel Vickers Smith, PhD University of Louisville College of Nursing Goals

More information

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01

More information

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain Canadian Guideline for Opioids for Chronic Non-Cancer Pain John Fraser Community Hospital Program New Glasgow November 1, 2017 This speaker has been asked to disclose to the audience any involvement with

More information

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Opioid Overdose Epidemic A Crises and Opportunity

Opioid Overdose Epidemic A Crises and Opportunity Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner

More information

Session 7: Opioids and Club Drugs 7-1

Session 7: Opioids and Club Drugs 7-1 Session 7: Opioids and Club Drugs 7-1 The Importance of Total Abstinence Abstinence from all substances that affect the brain even alcohol greatly increases the chances of a successful recovery. Matrix

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

Knock Out Opioid Abuse in New Jersey:

Knock Out Opioid Abuse in New Jersey: Knock Out Opioid Abuse in New Jersey: A Resource for Safer Prescribing GUIDELINE FOR PRESCRIBING OPIOIDS FOR CHRONIC PAIN IMPROVING PRACTICE THROUGH RECOMMENDATIONS CDC s Guideline for Prescribing Opioids

More information

Trauma, Pain, and Opioids The Pain of Trauma, the Trauma of Pain

Trauma, Pain, and Opioids The Pain of Trauma, the Trauma of Pain Trauma, Pain, and Opioids The Pain of Trauma, the Trauma of Pain Bennet Davis MD Director, Sierra Tucson Pain Program Medical Director, Weitzman Pain ECHO program President, Integrative Pain Center of

More information

A Snapshot of Substance Use: Licit and Illicit Drug Use Yesterday among People Who Inject Drugs in Australia ( ).

A Snapshot of Substance Use: Licit and Illicit Drug Use Yesterday among People Who Inject Drugs in Australia ( ). illicit drug reporting system july 2016 A Snapshot of Substance Use: Licit and Illicit Drug Use Yesterday among People Who Inject Drugs in Australia (2006-2015). Authors: Amy Peacock 1,2, Bethany Lusk

More information

2/21/2018. What are Opioids?

2/21/2018. What are Opioids? Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting

More information

Opioids and Heroin in Snohomish County. Marijuana and Opioid Prevention Training May 2018

Opioids and Heroin in Snohomish County. Marijuana and Opioid Prevention Training May 2018 Opioids and Heroin in Snohomish County Marijuana and Opioid Prevention Training May 2018 OPIOIDS 101 What are Opioids? Opioids 101 Opium Poppy Plant Opiates: A type of pain medication that is naturally

More information

Addressing Alaska s Opioid Epidemic From Understanding to Action

Addressing Alaska s Opioid Epidemic From Understanding to Action Addressing Alaska s Opioid Epidemic From Understanding to Action The opioid epidemic is devastating American families and communities. To curb these trends and save lives, we must help prevent addiction

More information

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O. Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of

More information

Dr Alistair Dunn. General Practitioner Whangarei

Dr Alistair Dunn. General Practitioner Whangarei Dr Alistair Dunn General Practitioner Whangarei 1982 Temgesic = Buprenorphine Sublingual opiate analgesic 0.2 mg Popular drug of abuse 1991 Temgesic NX = Bup & Nalxone Nalxone added to deter abuse 1999

More information

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS

More information

Opioid Use in Youth. Amy Yule M.D. March 2,

Opioid Use in Youth. Amy Yule M.D. March 2, Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin

More information

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President

More information

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place

More information

Heroin. Brain Research Institute, UCLA Alison Taylor

Heroin. Brain Research Institute, UCLA Alison Taylor Heroin Brain Research Institute, UCLA Alison Taylor Heroin H, Smack, Dope, Junk Can be purchased as a white powder White China or a dark resin Black Tar Opiates Derived from the opium poppy Morphine:

More information

Take Home Naloxone Report on supply and use to reverse an overdose

Take Home Naloxone Report on supply and use to reverse an overdose Take Home Naloxone Report on supply and use to reverse an overdose 2012-2016 1 Contents 1. Introduction 2. How the Take Home Naloxone Programme works 3. How information is collected 4. Patients supplied

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Buprenorphine treatment

Buprenorphine treatment South London and Maudsley NHS Foundation Trust Buprenorphine treatment Information for service users Page Buprenorphine treatment What is buprenorphine? Buprenorphine (trade name Subutex ) is an opioid

More information

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM April 28, 2017 Disclosure Relationship with commercial interests: None Professional roles: Addictions

More information

Opioids. Sergio Hernandez, MD

Opioids. Sergio Hernandez, MD Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general

More information

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any

More information

AUSTRALIAN. Capital Territory

AUSTRALIAN. Capital Territory AUSTRALIAN Capital Territory ISBN 978-0-7334-3792-2 NDARC 2018 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

Otterbein Police Department. Opioid Addition Awareness

Otterbein Police Department. Opioid Addition Awareness Otterbein Police Department Opioid Addition Awareness What are Opiates? Opioids are substances that act on opioid receptors to produce morphinelike effects. Medically they are primarily used for pain relief,

More information

Anyone Can Become Addicted. Anyone.

Anyone Can Become Addicted. Anyone. Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Illicit drug use in prisons

Illicit drug use in prisons Illicit drug use in prisons. Kieran Lynch Criminal Justice Programme Manager.PHE (Acknowledgements: Dr. George Ryan Criminal Justice Clinical Lead for PHE) Key Themes The drugs The people Update on Opiate

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

National Drug-Related Deaths Index

National Drug-Related Deaths Index HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Appraisal Methadone and buprenorphine for the management of opioid dependence Comments received from Consultees and Commentators on the draft scope

More information

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists

Slide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics

More information

Combating Opioid-related Overdose

Combating Opioid-related Overdose Combating Opioid-related Overdose Kelly Dunn, Ph.D. Assistant Professor Behavioral Pharmacology Research Unit Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine

More information

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs

More information

Data Driven Strategies

Data Driven Strategies Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words

More information

Module Two: Pharmacotherapies for Opioid Substitution Treatment

Module Two: Pharmacotherapies for Opioid Substitution Treatment Module Two: Pharmacotherapies for Opioid Substitution Treatment Neurobiology of Addiction Pharmacology of Opioids Methadone Buprenorphine Pharmacokinetics of Methadone & Buprenorphine Opioid effects Intoxication

More information

Prescription/OTC. Paola Caliguiran and Savanna Walker

Prescription/OTC. Paola Caliguiran and Savanna Walker Prescription/OTC Paola Caliguiran and Savanna Walker Facts Prescription drug abuse is when someone takes a medication that was prescribed for someone else or takes their own prescription in a way not intended

More information

Expert Peer Review for Carfentanil

Expert Peer Review for Carfentanil Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential

More information

What is the strategy?

What is the strategy? What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health

More information

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Prescription and Illicit Drug Overdoses: On the Rise Opioid Prescription and Illicit Drug Overdoses: On the Rise Cindy Haynes, MSA-PA, CHES Chronic Pain Program Coordinator Northern Piedmont Community Care Duke Division of Community Health Objectives Define

More information

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services

Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services www.randallwebber.com MAT clients are still addicted Truth: MAT clients will experience withdrawal symptoms if they stop

More information